Iwadate Y - Search Results

1

GADD34 activates p53 and may have utility as a marker of atherosclerosis.

Tomiyoshi G, Nakamura R, Shinmen N, Yoshida Y, Mine S, Machida T, Iwase K, Iwadate Y, Hiwasa T, Kuroda H. Tomiyoshi G, et al. Among authors: iwadate y. Front Med (Lausanne). 2023 May 9;10:1128921. doi: 10.3389/fmed.2023.1128921. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37228401 Free PMC article.

2

Acquisition of drug resistance by constitutive suppression of NF-kappaB in ras-transformed NIH3T3 mouse fibroblasts.

Sakaida T, Iwadate Y, Yamaji S, Uehara M, Noda A, Takiguchi M, Yamaura A, Hiwasa T. Sakaida T, et al. Among authors: iwadate y. Int J Oncol. 2003 Oct;23(4):1071-7. Int J Oncol. 2003. PMID: 12963987

3

Molecular classification and survival prediction in human gliomas based on proteome analysis.

Iwadate Y, Sakaida T, Hiwasa T, Nagai Y, Ishikura H, Takiguchi M, Yamaura A. Iwadate Y, et al. Cancer Res. 2004 Apr 1;64(7):2496-501. doi: 10.1158/0008-5472.can-03-1254. Cancer Res. 2004. PMID: 15059904

4

Proteome-based identification of molecular markers predicting chemosensitivity to each category of anticancer agents in human gliomas.

Iwadate Y, Sakaida T, Saegusa T, Hiwasa T, Takiguchi M, Fujimoto S, Yamaura A. Iwadate Y, et al. Int J Oncol. 2005 Apr;26(4):993-8. Int J Oncol. 2005. PMID: 15753994

5

Cathepsin D is a potential serum marker for poor prognosis in glioma patients.

Fukuda ME, Iwadate Y, Machida T, Hiwasa T, Nimura Y, Nagai Y, Takiguchi M, Tanzawa H, Yamaura A, Seki N. Fukuda ME, et al. Among authors: iwadate y. Cancer Res. 2005 Jun 15;65(12):5190-4. doi: 10.1158/0008-5472.CAN-04-4134. Cancer Res. 2005. PMID: 15958563

6

High serum level of plasminogen activator inhibitor-1 predicts histological grade of intracerebral gliomas.

Iwadate Y, Hayama M, Adachi A, Matsutani T, Nagai Y, Hiwasa T, Saeki N. Iwadate Y, et al. Anticancer Res. 2008 Jan-Feb;28(1B):415-8. Anticancer Res. 2008. PMID: 18383878 Free article.

7

Akt/protein kinase B overexpression as an accurate prognostic marker in adult diffuse astrocytoma.

Matsutani T, Nagai Y, Mine S, Murai H, Saeki N, Iwadate Y. Matsutani T, et al. Among authors: iwadate y. Acta Neurochir (Wien). 2009 Mar;151(3):263-8; discussion 268. doi: 10.1007/s00701-009-0199-3. Epub 2009 Feb 25. Acta Neurochir (Wien). 2009. PMID: 19240976

8

Activation of NFAT signal by p53-K120R mutant.

Shinmen N, Koshida T, Kumazawa T, Sato K, Shimada H, Matsutani T, Iwadate Y, Takiguchi M, Hiwasa T. Shinmen N, et al. Among authors: iwadate y. FEBS Lett. 2009 Jun 18;583(12):1916-22. doi: 10.1016/j.febslet.2009.04.041. Epub 2009 May 3. FEBS Lett. 2009. PMID: 19416725 Free article.

9

Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas.

Matsutani T, Hiwasa T, Takiguchi M, Oide T, Kunimatsu M, Saeki N, Iwadate Y. Matsutani T, et al. Among authors: iwadate y. J Exp Clin Cancer Res. 2012 Oct 11;31(1):85. doi: 10.1186/1756-9966-31-85. J Exp Clin Cancer Res. 2012. PMID: 23050879 Free PMC article.

10

Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas.

Adachi-Hayama M, Adachi A, Shinozaki N, Matsutani T, Hiwasa T, Takiguchi M, Saeki N, Iwadate Y. Adachi-Hayama M, et al. Among authors: iwadate y. BMC Cancer. 2014 Jun 18;14:452. doi: 10.1186/1471-2407-14-452. BMC Cancer. 2014. PMID: 24946857 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page